• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低强度激光疗法可抑制过敏性哮喘中的支气管收缩、Th2炎症和气道重塑。

Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma.

作者信息

Silva Vanessa R, Marcondes P, Silva M, Villaverde Antonio B, Castro-Faria-Neto Hugo C, Vieira Rodolfo P, Aimbire Flavio, de Oliveira Ana Paula L

机构信息

Nove de Julho University - UNINOVE, Laboratory of Pulmonary and Exercise Immunology - LABPEI, Rua Vergueiro 239/245, PO Box 01504-001, São Paulo, SP, Brazil.

Department of Science and Technology, Federal University of São Paulo, PO Box 12231-280, São José dos Campos, SP, Brazil.

出版信息

Respir Physiol Neurobiol. 2014 Apr 1;194:37-48. doi: 10.1016/j.resp.2014.01.008. Epub 2014 Jan 28.

DOI:10.1016/j.resp.2014.01.008
PMID:24486607
Abstract

Low-level laser therapy (LLLT) controls bronchial hyperresponsiveness (BHR) associated with increased RhoA expression as well as pro-inflammatory mediators associated with NF-kB in acute lung inflammation. Herein, we explore if LLLT can reduce both BHR and Th2 cytokines in allergic asthma. Mice were studied for bronchial reactivity and lung inflammation after antigen challenge. BHR was measured through dose-response curves to acetylcholine. Some animals were pretreated with a RhoA inhibitor before the antigen. LLLT (660 nm, 30 mW and 5.4 J) was applied on the skin over the right upper bronchus and two irradiation protocols were used. Reduction of BHR post LLLT coincided with lower RhoA expression in bronchial muscle as well as reduction in eosinophils and eotaxin. LLLT also diminished ICAM expression and Th2 cytokines as well as signal transducer and activator of transduction 6 (STAT6) levels in lungs from challenged mice. Our results demonstrated that LLLT reduced BHR via RhoA and lessened allergic lung inflammation via STAT6.

摘要

低强度激光疗法(LLLT)可控制与急性肺炎症中RhoA表达增加相关的支气管高反应性(BHR)以及与NF-κB相关的促炎介质。在此,我们探讨LLLT是否能降低过敏性哮喘中的BHR和Th2细胞因子。在抗原激发后,对小鼠的支气管反应性和肺部炎症进行了研究。通过对乙酰胆碱的剂量反应曲线来测量BHR。一些动物在抗原刺激前用RhoA抑制剂进行预处理。将LLLT(660纳米,30毫瓦和5.4焦耳)应用于右上支气管上方的皮肤,并使用了两种照射方案。LLLT后BHR的降低与支气管肌肉中RhoA表达的降低以及嗜酸性粒细胞和嗜酸性粒细胞趋化因子的减少相一致。LLLT还减少了受攻击小鼠肺部的细胞间黏附分子(ICAM)表达、Th2细胞因子以及信号转导和转录激活因子6(STAT6)水平。我们的结果表明,LLLT通过RhoA降低BHR,并通过STAT6减轻过敏性肺部炎症。

相似文献

1
Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma.低强度激光疗法可抑制过敏性哮喘中的支气管收缩、Th2炎症和气道重塑。
Respir Physiol Neurobiol. 2014 Apr 1;194:37-48. doi: 10.1016/j.resp.2014.01.008. Epub 2014 Jan 28.
2
A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice.一种新型信号转导和转录激活因子6(STAT6)抑制剂AS1517499可改善抗原诱导的小鼠支气管高收缩性。
Am J Respir Cell Mol Biol. 2009 Nov;41(5):516-24. doi: 10.1165/rcmb.2008-0163OC. Epub 2009 Feb 6.
3
A rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia, bronchoconstriction and airways hyperresponsiveness in allergic mice.一种Rho激酶抑制剂Y-27632可抑制变应性小鼠的肺部嗜酸性粒细胞增多、支气管收缩和气道高反应性。
Pulm Pharmacol Ther. 2005;18(1):67-74. doi: 10.1016/j.pupt.2004.10.002. Epub 2004 Nov 23.
4
Rho-kinase and contractile apparatus proteins in murine airway hyperresponsiveness.Rho激酶与小鼠气道高反应性中的收缩装置蛋白
Exp Toxicol Pathol. 2008 Jun;60(1):9-15. doi: 10.1016/j.etp.2008.03.002. Epub 2008 Apr 22.
5
Interleukin-4 upregulates RhoA protein via an activation of STAT6 in cultured human bronchial smooth muscle cells.白细胞介素-4 通过激活 STAT6 上调培养的人支气管平滑肌细胞中的 RhoA 蛋白。
Pharmacol Res. 2010 Feb;61(2):188-92. doi: 10.1016/j.phrs.2009.10.003. Epub 2009 Oct 24.
6
Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation.血管紧张素 -(1 - 7)可减轻慢性过敏性肺部炎症模型中的气道重塑和高反应性。
Br J Pharmacol. 2015 May;172(9):2330-42. doi: 10.1111/bph.13057. Epub 2015 Mar 18.
7
Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.大豆异黄酮对变应性哮喘小鼠气道炎症、高反应性和重塑的抑制作用。
Int Immunopharmacol. 2011 Aug;11(8):899-906. doi: 10.1016/j.intimp.2011.02.001. Epub 2011 Feb 26.
8
Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.熊果酸作为一种潜在的过氧化物酶体增殖物激活受体 γ(PPARγ)激动剂,通过下调变应性哮喘小鼠模型中白细胞介素-5(IL-5)、白细胞介素-13(IL-13)和白细胞介素-17(IL-17)的表达,抑制卵清蛋白(OVA)诱导的气道炎症和气道高反应性(Penh)。
Eur J Pharmacol. 2013 Feb 15;701(1-3):131-43. doi: 10.1016/j.ejphar.2012.11.033. Epub 2012 Nov 28.
9
Sites of allergic airway smooth muscle remodeling and hyperresponsiveness are not associated in the rat.在大鼠中,过敏气道平滑肌重塑和高反应性的部位并不相关。
J Appl Physiol (1985). 2010 Oct;109(4):1170-8. doi: 10.1152/japplphysiol.01168.2009. Epub 2010 Jul 22.
10
Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.去甲氧基环氧青蒿素(DHMEQ),一种新型 NF-κB 抑制剂,可抑制哮喘小鼠模型中的过敏炎症和气道重塑。
Clin Exp Allergy. 2012 Aug;42(8):1273-81. doi: 10.1111/j.1365-2222.2012.04007.x.

引用本文的文献

1
Twenty cases of perennial and seasonal allergic rhinitis treated with LumiMed® Nasal Device.用 LumiMed® 鼻腔装置治疗常年性和季节性过敏性鼻炎 20 例。
J Med Case Rep. 2023 Jun 14;17(1):263. doi: 10.1186/s13256-023-03980-4.
2
Photobiomodulation Therapy Restores IL-10 Secretion in a Murine Model of Chronic Asthma: Relevance to the Population of CD4CD25Foxp3 Cells in Lung.光生物调节疗法恢复慢性哮喘小鼠模型中的 IL-10 分泌:与肺中 CD4CD25Foxp3 细胞群体的相关性。
Front Immunol. 2022 Feb 2;12:789426. doi: 10.3389/fimmu.2021.789426. eCollection 2021.
3
Multi-Wavelength Photobiomodulation Therapy Combined with Static Magnetic Field on Long-Term Pulmonary Complication after COVID-19: A Case Report.
多波长光生物调节疗法联合静磁场治疗COVID-19后长期肺部并发症:一例报告
Life (Basel). 2021 Oct 22;11(11):1124. doi: 10.3390/life11111124.
4
Influence of photobiomodulation therapy on the treatment of pulmonary inflammatory conditions and its impact on COVID-19.光生物调节疗法对肺部炎症性疾病治疗的影响及其对 COVID-19 的影响。
Lasers Med Sci. 2022 Apr;37(3):1921-1929. doi: 10.1007/s10103-021-03452-5. Epub 2021 Oct 25.
5
Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19.红外光疗法可缓解由新冠病毒引起的TLR-4依赖性过度炎症。
Commun Integr Biol. 2021 Sep 15;14(1):200-211. doi: 10.1080/19420889.2021.1965718. eCollection 2021.
6
Effects of Photobiomodulation Therapy Combined with Static Magnetic Field in Severe COVID-19 Patients Requiring Intubation: A Pragmatic Randomized Placebo-Controlled Trial.光生物调节疗法联合静磁场对需要插管的重症 COVID-19 患者的影响:一项实用随机安慰剂对照试验
J Inflamm Res. 2021 Jul 24;14:3569-3585. doi: 10.2147/JIR.S318758. eCollection 2021.
7
Photobiomodulation Therapy as a Possible New Approach in COVID-19: A Systematic Review.光生物调节疗法作为治疗新型冠状病毒肺炎的一种可能新方法:一项系统综述
Life (Basel). 2021 Jun 18;11(6):580. doi: 10.3390/life11060580.
8
The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection.光生物调制疗法(PBMT)在新型冠状病毒肺炎感染中的有效性
J Lasers Med Sci. 2020 Fall;11(Suppl 1):S23-S29. doi: 10.34172/jlms.2020.S4. Epub 2020 Dec 30.
9
Methods of effective low-level laser therapy in the treatment of patients with bronchial asthma (literature review).支气管哮喘患者治疗中有效的低强度激光疗法(文献综述)
Biomedicine (Taipei). 2020 Mar 28;10(1):1-20. doi: 10.37796/2211-8039.1000. eCollection 2020.
10
Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review.光疗作为COVID-19管理中的一种合理抗氧化治疗方式;新概念与战略方法:批判性综述
Antioxidants (Basel). 2020 Sep 16;9(9):875. doi: 10.3390/antiox9090875.